Artificial Intelligence
Henlius and OncoHost partner to predict trial outcomes using machine learning
OncoHost’s PROphet platform will build patient selection and outcome profiles in the Phase III trial of serplulimab for small-cell lung cancer.
OncoHost’s PROphet platform will build patient selection and outcome profiles in the Phase III trial of serplulimab for small-cell lung cancer.